Shukra Pharmaceuticals Ltd - Board Meeting Outcome for Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Resignation of Mr. Mehul Patel from the post of Chief Financial Officer of the Company with effect from July 10, 2024, Appointment of Ms. Anar Jayesh Patel (DIN: 02588388 ), as Additional Director (Whole-time Director), liable to retire by rotation, designated as Executive Director for a period of 5 years with effect from July 10, 2024 to July 09, 2029 and appointment of Mr. Jitendra Somchand Shah ( DIN: 01609325), as an Additional Director categorized as Non - Executive Independent Director of the Company, for a term of 5 consecutive years w.e.f. July 10, 2024 to July 9 2029